cognitive cybersecurity intelligence

News and Analysis


Virtual biotech company uses data to boost CNS drug development

Biotech firm Libra Therapeutics is developing treatments for neurodegenerative diseases and aims to start Phase 1 clinical trials in 2025. The San Diego-based virtual company, established in 2020, outsources its R&D to contract research organisations (CROs) and relies heavily on data management platform CDD Vault to enable the comparison of diverse data from its CRO partners. Martin Gill, Libra’s Vice President and Head of Biology, stated the company is aiming to be first and best in its class.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts